Wall Street Analysts Believe Benitec Biopharma (BNTC) Could Rally 84.96%: Here's is How to Trade

Benitec Biopharma Limited (BNTC) closed the last trading session at $13.90, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 25.71 indicates an 85% upside potential.The average comprises seven short-term price targets ranging from a low of $17 to a high of$ 35, with a standard deviation of $6.70. While the lowest estimate indicates an increase of 22.3% from the current ...